-
-
-
-
-
-
-
NextCure delays LNCB74 trial data, expects SIM0505 results in Q2 2026
-
-
-
-
-
-
-
NextCure, Inc. (NXTC) Misses Q3 EPS by 6c
-
-
-
-
-
-
-
NextCure, Inc. (NXTC) Tops Q3 EPS by 15c
-
-
-
-
-
-
-
NextCure Provides Business Update and Reports Full Year 2022 Financial Results
-
-
-
-
-
-
-
Needham & Company Reiterates NextCure (NXTC) at Buy, Focus Remains on Upcoming Results of Yale Study
-
-
-
-
-
-
-
NextCure Reports First Quarter 2021 Financial Results
-
-
-
-
-
-
-
NextCure Reports Second Quarter 2020 Financial Results
-
1,223,268 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

